Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eiger Biopharma (NQ: EIGR )

1.095 -0.035 (-3.10%)
Streaming Delayed Price Updated: 3:23 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 110,314
Open 1.110
Bid (Size) 1.090 (145)
Ask (Size) 1.100 (7)
Prev. Close 1.130
Today's Range 1.080 - 1.129
52wk Range 0.7533 - 9.890
Shares Outstanding 34,639,884
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Recap: Eiger BioPharmaceuticals Q1 Earnings
 
Via Benzinga
Eiger BioPharmaceuticals Earnings Perspective: Return On Capital Employed
 
Via Benzinga

Performance

YTD
-11.69%
-11.69%
1 Month
-0.45%
-0.45%
3 Month
-41.76%
-41.76%
6 Month
-74.71%
-74.71%
1 Year
-84.22%
-84.22%

More News

Read More
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
Via Benzinga
Eiger BioPharma's Single Dose Of Peginterferon Lambda Cuts Risk Of COVID-19-Related Hospitalizations, Deaths
Via Benzinga
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Eiger BioPharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Long Term Investor Alert: Investigation of Potential Wrongdoing
Via SBWire
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Notifies Eiger BioPharmaceuticals, Inc. (EIGR) Investors of Class Action and Encourages Investors to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
EIGER DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR)
From Law Offices of Frank R. Cruz
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
EIGR FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 9 Deadline in Securities Class Action - EIGR
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vintage Wine, Eiger, Unisys, and Rent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Looking Into Eiger BioPharmaceuticals's Recent Short Interest
Via Benzinga
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - EIGR
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Eiger BioPharmaceuticals Announces Leadership Change
From Eiger BioPharmaceuticals, Inc.
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SolarEdge, Eiger, Unisys, and Rent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.